GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sunder Biomedical Tech Co Ltd (ROCO:4115) » Definitions » Debt-to-Revenue

Sunder Biomedical Tech Co (ROCO:4115) Debt-to-Revenue : 0.51 (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sunder Biomedical Tech Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Sunder Biomedical Tech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$206.8 Mil. Sunder Biomedical Tech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$192.9 Mil. Sunder Biomedical Tech Co's annualized Revenue for the quarter that ended in Jun. 2024 was NT$780.7 Mil. Sunder Biomedical Tech Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 was 0.51.


Sunder Biomedical Tech Co Debt-to-Revenue Historical Data

The historical data trend for Sunder Biomedical Tech Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunder Biomedical Tech Co Debt-to-Revenue Chart

Sunder Biomedical Tech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial 0.60 0.66 0.46 0.45 0.64

Sunder Biomedical Tech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.49 0.64 0.61 0.51

Competitive Comparison of Sunder Biomedical Tech Co's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Sunder Biomedical Tech Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunder Biomedical Tech Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sunder Biomedical Tech Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sunder Biomedical Tech Co's Debt-to-Revenue falls into.



Sunder Biomedical Tech Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Sunder Biomedical Tech Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(262.942 + 228.345) / 770.191
=0.64

Sunder Biomedical Tech Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(206.836 + 192.889) / 780.74
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2024) Revenue data.


Sunder Biomedical Tech Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sunder Biomedical Tech Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunder Biomedical Tech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1-67, Zhongzheng Road, Chung-Ming Village, Pao-Chung Hsiang, Yunlin, TWN, 63441
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.

Sunder Biomedical Tech Co Headlines

No Headlines